BridgeMD
New treatment option for Autism Spectrum Disorder
Official title More and Less Social Comprehension
ClinicalTrials.gov ID: NCT06116552
What this study is testing
- What it's testing
- The goal of this early Phase 1 clinical trial is to assess if the social content of a story impacts autistic children's listening comprehension of stories. The main questions this study aims to answer are: Does removing social content from a story improve listening comprehension in autistic children?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 9 to 12
You may be able to join if
- Has a community or educational autism diagnosis (based on parent report);
- Is between the ages of 9;0 to 12;11 (years; months);
- Uses verbal phrase-level spoken language (based on parent report).
You likely can't join if
- Speaks more than one language (based on parent report);
- Has a known chromosomal abnormality (e.g., Fragile X syndrome, Down syndrome; based on parent report);
- Has an intellectual impairment or cognitive disability (IQ \< 70; based on parent report);
- Has Cerebral palsy (based on parent report);
- Uncorrected visual impairments (based on parent report);
- Minimal spoken language or no phrase spoken language (based on parent report or clinical observation).
The study team makes the final eligibility decision.
Where it's taking place
- Lawrence, Kansas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 9 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lawrence, Kansas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.